More articles from ODT: In vitro and In vivo Oncology 

You have access
Differentiating High Grade Glioma Recurrence from Radiation Treatment Effects Using 18F-MeFAMP vs 18F-FET: A Comparative Preclinical Study
Ugur Akca, Rodrigo Queiroz, Norio Yasui, Carlos Gallegos, Yun Lu, Kadir Gultekin, Anna Sorace and Jonathan Mcconathy

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 252243;
You have access
Reprogramming the Tumor Microenvironment with Mannosylated Liposomes Encapsulating Zoledronic Acid to Target M2 Tumor-Associated Macrophages
Gayoung Lee, Eun jin Cho, Sera Oh, Jong hyun Lee, Seok-yong Lee, Keon wook Kang and Hyewon Youn

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 252092;
You have access
Synergistic Combination of Radiopharmaceutical Therapy and DNA Damage Repair Inhibition for Triple Negative Breast Cancer
Yadira Medina guevara, Hansel Rojas, hansel, Malick Bio idrissou, Ohyun Kwon, Liudmila Lambert, Anatoly Pinchuk, Lauren Wehner, Amanda Carston, Nathan Clemons, Bryan Bednarz, Jamey Weichert and Reinier Hernandez

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 252055;
You have access
Harnessing LDLR-targeted radiolabeled peptide for imaging in pancreatic adenocarcinoma (PDAC)
Izabela Tworowska, Leo Flores ii, Cedric Malicet, Xiaomei Qu, Perry Davis, Pascaline Lecorche, Jamal Temsamani and Ebrahim Delpassand

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251896;
You have access
Simultaneous targeting of EGFR-positive TNBC xenografts using epitope-specific [225Ac]Ac-labeled nimotuzumab and [161]Tb-labeled matuzumab results in enhanced therapeutic effects
Dede Fon, Florence Tikum, Fabrice ngoh Njotu, Jessica Pougoue ketchemen, Nikita Henning, Hanan Babeker, Maruti Uppalapati and Humphrey Fonge

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 252248;
You have access
Development of a Peptide-Drug Conjugate to Enhance DNA Alkylating Effects in Neuroendocrine Tumors
Tyler Bateman, Jack Adams, Sukhen Ghosh, Vahid Khalaj, Ali Azhdarinia and Solmaz Aghaamiri

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251844;
You have access
PET imaging and optimization of HER2 modulation in HER2-low breast tumors to enhance therapeutic efficacy
Patricia Ribeiro pereira, Alexander Vanover, Cristina Simó, Alex Benton, Farrokh Dehdashti and Andrew Davis

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 252245;
You have access
Granzyme B PET imaging of biomimetic tumor vaccine combined with [177Lu]Lu–CXCR4 in triple negative breast cancer
Ruolin Wu, Yuyue Hou, Zairong Gao and Xiaotian Xia

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251360;
You have access
Precise monitoring of acquired drug resistance in melanoma by ACC-targeted PET imaging
Jiajun Ye, Xiaobo Wang, Yu Kangxia, Weidong Yang, Fei Kang and Jing Wang

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251644;
You have access
[177Lu]Lu-VG-FAP-01, a Novel Cyclic Radiopeptide Targeting Fibroblast Activation Protein alpha (FAP)
Haihong Jin, Xiaobo Su, Jinsong Cao, Chengzhen Ge, David Mozley and Keene Wei

Journal of Nuclear Medicine June 1, 2025, 66 (supplement 1) 251372;

Main menu

User menu

Search

More articles from ODT: In vitro and In vivo Oncology

Pages